[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cardiac and Lung Surgical Robots Market Shares, Strategies, and Forecasts, Worldwide, 2015 to 2021

December 2015 | 223 pages | ID: C3556E6E301EN
WinterGreen Research

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
LEXINGTON, Massachusetts (December 9, 2015) – WinterGreen Research announces that it has published a new study Cardiac and Lung Surgical Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021. The 2015 study has 223 pages, 85 tables and figures. Worldwide Cardiac and Lung surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and decrease the number of ports needed for minimally invasive surgery.

The automated process revolution in surgery and communications is being implemented via robots. Robots automation of systems is providing significant improvement in the accuracy of surgery and the repeatability of process.

Intuitive Surgical owns the market as the major participant with compelling market share in cardiac and lung surgical robots. This leadership position will need to be defended as other vendor products, now in clinical trials come to market. Advanced technology, an installed base and a well trained core group of surgeons give Intuitive Surgical market advantage.

Patients for some types of procedures fare better when the heart or lung surgery is done by surgical robots. The documentation of improvements in care delivery, the ability to ensure better outcomes from surgery promise that cardiac and lung surgical robotics is a strong growth market. Heart disease is still the largest disease worldwide. The issue for cardiac and lung robotic surgery is that so many heart patients exist.

Every leading surgeon working to perform heart and lung robotic surgery has worked to be accepted to practice at a hospital that has those robotic devices. The really talented surgeons depend on hospitals having the cardiac robotic equipment. In order to attract physicians and patients, the hospitals have to purchase the surgical equipment.

The market penetration of the cardiac and lung surgical robots will go to 100 percent in the US top hospitals within five years. As the surgeons migrate to the places that have the robotic surgical equipment, other hospitals and their potential patient populations notice. If the hospital does not have the surgical robotic equipment, it will not have any surgeons, this is a bad situation for a hospital. The cardiac and lung robotic surgical equipment permits better surgery and the surgeons and patients know this.

Cardiac and lung robotic surgery is poised to eclipse open surgery. It is used in the categories of lobectomy, thoracic revascularization, and mitral valve repair surgery. Surgical robots are positioned to become the standard of care for hospitals in the delivery of some heart surgery. The emerging group of several surgical robotic companies will collectively have enough marketing dollars and enough marketing clout to drive replacement of virtually all open cardiac and lung surgery.

Larger hospitals that can afford the expenditure are adopting heart and lung robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Hospital robotic systems have an emphasis on outcomes improvement during surgery. This has resulted in investment in robotics technology that is useful, and achieves positive patient outcomes.

Technology is enhancing a wide variety of procedures in many cardiac surgical specialties. Cardiac and thoracic surgeons at leading hospitals use robotic surgical systems increasingly. The aim is to perform more of the one-hundred thousand MIS surgical procedures of various types using robots. The surgeries performed by robot include cardiothoracic and vascular surgery. These surgical applications are cleared by the FDA.

The technology uses metal tubes attached to the arms are inserted through the ports, and the cutting and visualization instruments are introduced through the tubes into the patient’s body. The surgeon performs the procedure while sitting at a console, manipulating the instrument controls and viewing the operation through a vision system. When a surgeon needs to change an instrument the instrument is withdrawn from the surgical field using the controls at the console and the nursing assistants switch instruments as per the physician instruction. This is done many times during an operation.

The cardiac and lung surgical robot market is characterized enormous variety and innovation. A surgical robot recurring revenue business model is essentially a large one time purchase for a system complimented by replaceable or disposable instruments that cumulatively make the market a much larger and sustainable ongoing market. Vendors make money from the one time sale of a system and recurring revenue from sale of devices used in every operation.

Initially, a vendor sells and installs the surgical system into new customer accounts. Once systems are sold into customer accounts, the vendor generates recurring revenue as customers use the system to perform surgery. To do cardiac and lung robotic surgeries, the customers need to buy and consume instruments and accessory products. Vendors also generate recurring revenue from system service.

According to Susan Eustis, lead author of the study, “Existing open cardiac and lung surgery can be replaced in some part by robotic surgery during the forecast period. Cardiac and lung robotic surgical approaches complement existing open surgery techniques. Soon, all surgery will be undertaken with at least come aspects of robotic surgery replacing or complementing open surgery.”

The aging US population has supported demand, since the occurrence of health issues that require medical devices is higher in the elderly population. Buoyed by strong demand and sales, industry profit margins have increased considerably during the past five years.

Hospitals are adopting robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Hundreds of universities worldwide have research programs in robotics and many are awarding degrees in robotics. These “roboticists” are increasingly being hired by Global 2000 organizations to link mobile robots (mobile computers) into existing IT systems. Robot-assisted surgery gives the surgeon better control over the surgical instruments and a better view of the surgical site. Surgeons no longer have to stand throughout the surgery and do not tire as quickly.

Hand tremors are filtered out by the robot’s computer software. The surgical robot can continuously be used by rotating surgery teams. 3D viewing of the surgical site on a large screen improves visualization of the surgical operating field.

Cardiac and lung surgical robot device markets at $72.2 million in 2014 are anticipated to reach $2.2 billion by 2021 as next generation devices, systems, and instruments are introduced to manage surgery through small ports in the body instead of large open wounds.

The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success, challenges, and strategies in each segment and sub-segment. The reports cover markets for Cardiac and Lung robotic surgery medical specialties and sub-specialties.

WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, Bloomberg, and Thompson Financial. It conducts its business with integrity.

WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, and Thompson Financial. WinterGreen Research is positioned to help customers facing challenges that define the modern enterprises. The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise. Customers trust wintergreen research to work alongside them to ensure the success of the participation in a particular market segment.

WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.
HEART AND LUNG SURGICAL ROBOT EXECUTIVE SUMMARY

Heart and Lung Surgical Robot Market Driving Forces
  Surgical Robotics Market Driving Forces
  Cardiac Surgical Robot Key Procedures As Elements Of Strategy
Cardiac and Lung Surgical Robots Market Share Analysis
Cardiac and Lung Surgical Robot Market Forecasts

1. CARDIAC SURGICAL ROBOT MARKET DESCRIPTION AND MARKET DYNAMICS

1.1 Cardiac Robotic Surgical Clinical Applications
  1.1.1 Robotic Cardiothoracic Surgery
  1.1.2 Mitral Valve Repairs Are Preferred Over Mitral Valve Replacement
  1.1.3 Mitral Valve Repair
  1.1.4 Mitral Valve Replacement Possible Complications
1.2 Interventional Cardiologists Treatments and Procedures
1.3 Robotic Internal Thoracic Artery Dissection
  1.3.1 Robotic Thoracoscopy
  1.3.2 Cardiothoracic Surgery
1.4 Surgical Robotic Lobectomy
1.5 Robotic Coronary Artery Bypass

2. HEART AND LUNG SURGICAL ROBOT MARKET SHARES AND MARKET FORECASTS

2.1 Heart and Lung Surgical Robot Market Driving Forces
  2.1.1 Surgical Robotics Market Driving Forces
  2.1.1 Cardiac Surgical Robot Key Procedures As Elements Of Strategy
2.2 Cardiac and Lung Surgical Robots Market Share Analysis
  2.2.1 Intuitive Surgical da Vinci Surgical System Is Food and Drug Administration (FDA) Approved Cardiac and Lung Robotic System
  2.2.2 Corindus
  2.2.3 MedRobotics
2.3 Cardiac and Lung Surgical Robot Market Forecasts
2.4 Cardiac and Lung Surgical Robot Installed Systems and Procedure Volumes by Country
2.5 Key Players In The Global Medical Surgical Robots Market
2.6 Robotic Surgery Equipment Prices
  2.1.2 Intuitive Surgical da Vinci Surgical System Prices
2.7 Cardiac and Lung Robotic Surgery Equipment Regional Market Segments
  2.7.1 Intuitive Surgical Regional Revenue
  2.7.2 Intuitive Surgical European Demand
  2.7.3 Intuitive Surgical in Japan
  2.7.4 U.S. Robotic Surgical Procedures
  2.7.5 BRIC (Brazil, Russia, India, China) countries
  2.7.6 Aging Taiwanese Population
  2.7.7 Korea Focusing On Creating A Growth Engine In Research & Development
  2.7.8 Korea
  2.7.9 Brazil
  2.7.10 Chinese Imported Surgical Robots
  2.7.11 Chinese Development of Surgical Robots
2.8 Chinese Robotic Cardiac Surgery
  2.8.1 Chinese Robotic Cardiac Team Recognized As One Of World's Best

3. CARDIAC SURGICAL ROBOTS PRODUCT DESCRIPTIONS

3.1 Intuitive Surgical Cardiothoracic Surgeries
  3.1.1 Intuitive Surgical da Vinci Surgical System
  3.1.2 Intuitive Surgical Da Vinci Minimally Invasive Surgical Product
  3.1.3 Intuitive Surgical Cardiac Surgery
  3.1.4 Intuitive Surgical da Vinci Surgical System Components
  3.1.5 Intuitive Surgical Patient-Side Cart and Electromechanical Surgical Arms
  3.1.6 Intuitive Surgical 3-D Vision System
  3.1.7 Intuitive Surgical Firefly Fluorescence Imaging
  3.1.8 Intuitive Surgical. da Vinci Surgical System EndoWrist Instruments
  3.1.9 Intuitive Surgical Instruments and Accessories
  3.1.10 Intuitive Surgical da Vinci Single-Site
  3.1.11 Intuitive Surgical EndoWrist One Vessel Sealer
  3.1.12 Intuitive Surgical da Vinci Skills Simulator
3.2 Titan Medical
3.3 Johnson & Johnson
  3.3.1 Johnson & Johnson Ethicon
3.4 MedRobotics
  3.4.1 Medrobotics Flex Retractor
  3.4.2 Medrobotics Flexible Robot Platform
  3.4.3 Medrobotics Snakelike Robots for Oropharynx, Hypopharynx and Larynx Surgery116
3.5 Corindus
  3.5.1 CorPath Robotic Angioplasty
  3.5.2 Corindus Command. Control CorPath 200 System
  3.5.3 Corindus Standard in Precision PCI
  3.5.4 Robotic Angioplasty/Interventional Cardiology
3.6 Changzhou Kangxin Medical Instruments Co., Ltd.
3.7 Guangzhou Baitang Medical Instrument Co., Ltd.

4. CARDIAC SURGICAL ROBOTS TECHNOLOGY AND RESEARCH

4.1 Intuitive Surgical Da Vinci Computerized Technology For Surgery
4.2 Intuitive Surgical da Vinci Xi Surgical System Minimally Invasive Surgery
  4.2.1 Intuitive Surgical da Vinci Surgical System
4.3 Third Party Reimbursement

5. CARDIAC AND LUNG SURGICAL ROBOTS COMPANY DESCRIPTIONS

5.1 Chinese Surgical Robots
5.2 Corindus
  5.2.1 Corindus Benefits of CorPath Robotic-Assisted PCI
  5.2.2 Corindus Improves Staff Position in the Room
5.3 Freehand
  5.3.1 Freehand 2010/Prosurgics
5.4 Intuitive Surgical
  5.4.1 Intuitive Surgical Robotics da Vinci Surgical System
  5.4.2 Intuitive Surgical Robotics da Vinci Surgical System Xi
  5.4.3 Intuitive Surgical Business Strategy
  5.4.4 Intuitive Surgical Systems
  5.4.5 Intuitive Surgical Patient Value As Equal To Procedure Efficacy/Invasiveness
  5.4.6 Intuitive Surgical Business Model
  5.4.7 Intuitive Surgical Revenue
  5.4.8 Intuitive Surgical Regulatory Activities
  5.4.9 Intuitive Surgical Economic Environment.
5.5 Johnson and Johnson/DePuy Synthes
  5.5.1 Google Collaborating With Johnson & Johnson To Develop Surgical Robots
  5.5.2 DePuy
  5.5.3 Johnson & Johnson
  5.5.4 Johnson & Johnson/Ethicon
5.6 Medrobotics
  5.6.1 Medrobotics Closes On $10 Million Financing
  5.6.2 Medrobotics Several Generations Of Snake Robot Platforms
  5.6.3 Medrobotics Advances Clinical Development of Snake Robot for Surgery
  5.6.4 Medrobotics Positioning
  5.6.5 Medrobotics Cardiac Surgery Gold Standard
  5.6.6 Medrobotics Snake Robot Technologies For Use In A Wide Range Of Surgical And Interventional Applications
  5.6.7 Medrobotics Technology & Research Center
5.7 Medtronic
  5.7.1 Medtronic PLC
  5.7.2 Medtronic O-arm Surgical Imaging System
5.8 Meerecompany/Eterne
5.9 Titan Medical
  5.9.2 Titan Medical General Surgery Robot Market Opportunities
  5.9.3 Titan Medical Robotic Surgery Target Opportunity
5.10 TransEnterix Acquires the ALF-X Surgical Robotic System
  5.10.2 TransEnterix Strategic Positioning
  5.10.3 TransEnterix
  5.10.4 TransEnterix/Sofar
5.11 Surgical Robot Companies

LIST OF TABLES AND FIGURES

Table ES-1 Innovative Surgical Robot Features
Table ES-2 Surgical Robotics Market Driving Forces
Table ES-3 Surgical Robot Market Positioning
Table ES-4 Cardiac and Lung Surgical Robot Medical Sub-Specialties
Figure ES-5 Cardiac and Lung Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2014
Figure ES-6 Cardiac and Lung Surgical Robot Systems Forecasts, Dollars, Worldwide, 2015-2021
Table 1-1 Cardiac Conditions Requiring Surgery
Table 1-2 Intuitive Surgical Robotic Cardiac Procedures
Table 1-3 Robotic Surgery Surgical Specialty Focus
Table 1-4 Mitral Valve Problem Description
Table 1-5 Causes Of Mitral Valve Problems
Table 1-6 Mitral Valve Replacement Possible Complications
Table 1-7 Factors That May Increase The Risk Of Complications With Heart Surgery
Table 1-8 Physician-Patient Mitral Valve Heart Valve Assessment Program Aspects
Table 1-9 Catheter-Based Valve Disease Procedures
Table 1-10 Cardiac Surgeon Open Surgical Procedures
Table 2-1 Innovative Surgical Robot Features
Table 2-2 Surgical Robotics Market Driving Forces
Table 2-3 Surgical Robot Market Positioning
Table 2-4 Cardiac and Lung Surgical Robot Medical Sub-Specialties
Figure 2-5 Cardiac and Lung Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2014
Table 2-6 Cardiac and Lung Surgical Robot Market Shares, Dollars, Worldwide, 2014
Figure 2-7 Cardiac and Lung Surgical Robot Systems Forecasts, Dollars, Worldwide, 2015-2021
Table 2-8 Heart and Lung Surgical Robot Market Segment Forecasts, Dollars and Units, Worldwide, 2015-2021
Table 2-9 Number Intuitive Surgical Cardio/Thoracic Robotic Procedures, Regional Analysis by Procedure Type, 2014
Table 2-10 Open and Robotic Surgeries: Cardio Thoracic Procedure Forecasts, Number US and Worldwide, 2015-2021
Table 2-11 Cardio Thoracic Robotic Surgery Procedures By Country, 2014
Table 2-11 (Continued) Abdominal/Cardio Thoracic Robotic Surgery Procedures By Country, 2014
Table 2-12 Cardio Thoracic Robotic Surgery Procedure Forecasts, Lobectomy, Mitrial Valve Repair, Vascular Surgery, Number of Procedures, Worldwide, 2015-2021
Figure 2-13 Cardiac and Lung Surgical Robot Regional Market Segments, Dollars, 2014
Figure 2-14 Cardiac and Lung Surgical Robot Regional Market Segments, 2014
Figure 2-15 China Robotic Cardiac Surgery
Figure 3-1 Intuitive Surgical Integrated Sub – Systems
Figure 3-2 Intuitive Surgical da Vinci Surgical System
Figure 3-3 Intuitive Surgical Da Vinci Surgery
Table 3-4 Intuitive Surgical Da Vinci Surgical System Components
Table 3-5 Intuitive Surgical Cardiac Conditions Addressed
Table 3-6 Minimally Invasive Da Vinci Surgery Benefits To Cardiac Patients
Figure 3-7 Intuitive Surgical da Vinci System State-Of-The-Art Robotic Surgical Platform
Table 3-8 Intuitive Surgical da Vinci Si Surgical System Core Benefits
Figure 3-9 Intuitive Surgical da Vinci SI Surgical System Dual Console Used For Training And Collaboration
Figure 3-10 Intuitive Surgical. da Vinci Surgical System Vision System
Table 3-11 Intuitive Surgical da Vinci Xi Surgical System Surgeon Console Features
Figure 3-12 Intuitive Surgical. da Vinci Surgical System Surgeon Console
Figure 3-13 Intuitive Surgical. da Vinci Surgical System Patient-Side Cart
Figure 3-14 Intuitive Surgical. da Vinci Surgical System EndoWrist Instruments
Table 3-15 Intuitive Surgical da Vinci Surgical System Features
Table 3-16 Advantages of Intuitive Surgical Cardio Thoracic Robotic Surgery
Table 3-17 Surgical Robot Cardiothoracic Conditions Treated
Figure 3-18 Intuitive Surgical da Vinci Surgical System, Surgeon Operates Seated Comfortably At A Console
Figure 3-19 Intuitive Surgical da Vinci Surgical System Patient Side Cart
Figure 3-20 Titan Single Port Orifice Robotic Technology SPORT Surgical System
Figure 3-21 Titan SPORT Surgical System
Table 3-22 Titan MedicalSPORT Surgical System Patient Benefits
Table 3-23 Titan MedicalSPORT Surgical System Surgeon Benefits
Table 3-24 Johnson & Johnson Ethicon Minimally Invasive Procedures As They Apply To Specific Conditions
Figure 3-25 Medrobotics Flex Retractor
Figure 3-26 Medrobotics Snakelike Robot Tested for Heart Surgery
Table 3-27 Medrobotics Medical Field Target Markets
Figure 3-28 Corindus CorPath Robotic Angioplasty
Figure 3-29 Corindus Command. Control CorPath 200 System
Figure 3-30 Corindus Precise Robotic Movement And Device Fixation
Table 3-31 Corindus Robotic-Assisted Control Benefits
Figure 3-32 Occupational Hazards in Cath Lab
Figure 3-33 Corindus Robotic Assisted PCI
Figure 4-1 Intuitive Surgical da Vinci Surgical System
Figure 5-1 Tianjin Municipality Micro Hand A Chinese Surgical Robots
Figure 5-2 China's First Surgical Robot For Minimally Invasive Surgery At Tianjin Municipality
Table 5-3 Benefits of Corindus CorPath Robotic-Assisted PCI
Figure 5-4 Corindus CorPath Benefits
Table 5-5 Corindus Benefits of CorPath Robotic-Assisted PCI
Figure 5-6 Corindus Step Away From Radiation Source During Robotic PCI
Table 5-7 Corindus CorPath Robotic-Assisted PCI Mean Radiation Dose (per procedure) By Position (μSV)2
Figure 5-8 Intuitive Surgical Platform, daVinci Xi
Table 5-9 Intuitive Surgical Strategy To Improve Candidate Surgical Procedures
Table 5-10 Johnson and Johnson Family of Companies Comprises
Table 5-11 Medrobotics Positioning 2015
Table 5-12 Medrobotics Cardiac Surgery Improvements
Table 5-12 Medrobotics Snake Robot Technologies For Use In A Wide Range Of Surgical And Interventional Applications
Table 5-13 Medrobotics Snake Robot Technologies Specialist Areas Served
Table 5-14 Medtronic O-arm Surgical Imaging StealthStation Navigation Functions
Table 5-15 Medtronic O-arm Surgical Imaging System Benefits
Table 5-16 Medtronic O-arm Surgical Imaging System
Table 5-17 Medtronic O-arm Surgical Imaging System Benefits
Figure 5-18 Medtronic Lumbar Imaging
Table 5-19 Titan Medical Investment Summary
Figure 5-20 Titan Medical Business Goals and Timetable
Figure 5-21 Titan Medical Describes Robotic General Surgery Market Potential
Figure 5-22 Titan Medical Robotic Surgery Target Opportunity
Table 5-23 TransEnterix Strategic Positioning
Figure 5-24 TELELAP Robotic Surgical Unit
Figure 5-25 Telelap ALF-X Robotic Surgery
Figure 5-26 TELELAP ALF-X Breaking Barriers Supporting Precision


More Publications